Reimbursement, consolidation & more: 4 takeaways on the ASC market

Analysts expect the ambulatory surgery center market to flourish through 2021, a Markets Report World report predicted.

Advertisement

Here are four takeaways:

1. Many investors are seeking out ASCs for their cost lowering abilities in healthcare’s consolidating market.

2. The growth of minimally invasive surgeries is also propelling the market forward.

3. Unfavorable reimbursement may hinder market expansion.

4. AmSurg, Envision Healthcare Holdings, Hospital Corporation of America and Tenet Healthcare are some of the key companies operating in the market.

More articles on surgery centers:
Surgery Partners pays $760M for National Surgical Healthcare: 5 things to know
HCA to change its name — again; Tenet selects market CEO & more — 4 ASC company notes
Great Lakes Surgery Center opens in Michigan: 5 key notes

 

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in ASC News

Advertisement

Comments are closed.